Summary

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.58 for the 2023 fiscal year.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● Low profitability weakens the company.

● The company is in debt and has limited leeway for investment

● Most analysts recommend that the stock should be sold or reduced.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.